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Abstract
Background: Many children with type 1 diabetes have poor glycaemic control. Since the Diabetes Control and 
Complications Trial (DCCT) showed that tighter control reduces complication rates, there has been more emphasis on 
intensified insulin therapy. We know that patients and families are afraid of hypoglycaemia. We hypothesised that fear 
of hypoglycaemia might take precedence over concern about long-term complications, and that behaviour to avoid 
hypoglycaemia might be at the cost of poorer control, and aimed to evaluate the effectiveness of any interventions 
designed to prevent that. The objective of this review was to systematically review studies concerning the extent and 
consequences of fear of hypoglycaemia in parents of children under 12 years of age with type 1 diabetes, and 
interventions to reduce it.
Methods: Data Sources: MEDLINE, EMBASE, PsycINFO, The Cochrane Library, Web of Science, meeting abstracts of 
EASD, ADA and Diabetes UK, Current Controlled Trials, ClinicalTrials.gov, UK CRN, scrutiny of bibliographies of retrieved 
papers and contact with experts in the field.
Inclusions: Relevant studies of any design of parents of children under 12 years of age with Type 1 diabetes were 
included. The key outcomes were the extent and impact of fear, hypoglycaemia avoidance behaviour in parents due to 
parental fear of hypoglycaemia in their children, the effect on diabetes control, and the impact of interventions to 
reduce this fear and hypoglycaemia avoidance behaviour.
Results: Eight articles from six studies met the inclusion criteria. All were cross sectional studies and most were of good 
quality. Parental fear of hypoglycaemia, anxiety and depression were reported to be common. There was a paucity of 
evidence on behaviour to avoid hypoglycaemia, but there were some suggestions that higher than desirable blood 
glucose levels might be permitted in order to avoid hypoglycaemia. No studies reporting interventions to reduce 
parental fear of hypoglycaemia were found.
Conclusions: The evidence base was limited. Parents of children with Type 1 diabetes reported considerable parental 
fear of hypoglycaemia, affecting both parental health and quality of life. There is some suggestion that hypoglycaemia 
avoidance behaviours by parents might adversely affect glycaemic control. Trials of interventions to reduce parental 
anxiety and hypoglycaemia avoidance behaviour are needed. We suggest that there should be a trial of structured 
education for parents of young children with Type 1 diabetes.
Background
Type 1 diabetes mellitus is one of the most common
childhood diseases. It is characterised by hyperglycaemia,
caused by an absolute insulin deficiency [1]. Type 1 dia-
betes is usually diagnosed in childhood and adolescence
and is the leading form of diabetes in young white people,
especially those of northern European ancestry [2]. The
incidence has been increasing in children younger than
15 years, trebling in Scotland over the last 30 years. The
biggest relative increase has been in those under 5 years
old. It is predicted that in European children under the
age of 5 years, the incidence rate will double between
2005 and 2020, with prevalent cases younger than 15
years rising by 70% [2].
The long-term complications of diabetes include two
forms of vascular disease. Micro-vascular disease causes
retinopathy, nephropathy and neuropathy (which
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increases the risk of foot ulcers and sexual dysfunction).
Most people will develop microvascular complications
after 15-20 years of poorly controlled diabetes [3].
Macrovascular disease causes heart disease and stroke.
Heart disease is the main cause of death in type 1 diabetes
in developed countries [4]. There is also evidence that
chronic hyperglycaemia (particularly in young boys)
could be related to poorer neuro-cognitive outcomes.
Evidence from the Diabetes Control and Complications
Trial [5] and its long-term follow-up study, the Epidemi-
ology of Diabetes Interventions and Complications
(EDIC) study [6], have shown that a period of poor con-
trol can cause lasting damage - the "metabolic memory"
effect-even if control later improves. It is therefore
important to aim at good control from diagnosis.
Scottish audit data showed that only 10% of children
were meeting the NICE guideline target for blood glucose
control [7]. Similar data from England and Wales showed
that 19% of children in participating centres achieved that
target. This data shows that 81% of both 0-5 year olds and
6-11 year olds, fail to achieve a target HbA1c of less than
7.5% [8]. Furthermore, 28% of children under 12 years old
have very poor control, i.e. above 9.5% HbA1c.
Following evidence from the DCCT [5] that indicated
improved control by intensive insulin treatment reduced
complication rates, there has been a drive towards more
intensive insulin regimens. These involve not just more
injections, but regular self-measurment of blood glucose,
self-adjustment on insulin dose, and attention to diet and
other lifestyle factors. One consequence of the intensified
control in DCCT was a marked increased in the fre-
q u e n c y  o f  h y p o g l y c a e m i a  [ 9 ] .  I n  v e r y  y o u n g  c h i l d r e n ,
there is concern that severe hypoglycaemia can cause
some cognitive impairment [10]. Hypoglycaemia is one of
the most important barriers to good glycaemic control.
For young children, most care comes from parents who
administer or oversee treatment [11]. Up to the age of 8
years, parents have sole responsibility for diabetes man-
agement tasks (or securing suitably qualified or experi-
enced childcare), whilst between ages 8-11 children begin
to take over some of those tasks. By adolescence, a nego-
tation occurs between parents and adolescents about the
transfer of responsibility for diabetes with the main bur-
den of care being lifted off parents [12]. Hence this review
focuses on the under 12s only.
Diabetes management often has negative consequences
on parents' own well-being. New routines must be intro-
duced and maintained, new knowledge learned and cop-
ing strategies developed to adapt to life with a child with
Type 1 diabetes. Diabetes-related management practices,
time demands, finances, social support, independence,
stigma and concern for the future must all be balanced
with achieving optimal glycaemic control and quality of
life (QoL) for their child [13].
Children and their families 'learn quickly that hypogly-
caemic episodes are physically aversive, potentially dan-
gerous and a source of possible social
embarrassment'[14]. As such, they 'acknowledge signifi-
cant anxiety about the occurrence of hypoglycaemic epi-
sodes and maintain marginally elevated blood glucose
levels and engage in premature treatment of apparent
hypoglycaemia'[15]. The associated risks of long term
complications may be overshadowed by short term goals
to avoid hypoglycaemia. This "hypoglycaemia avoidance
behaviour" in the parents may lead to poorer glycaemic
control, in their children, increasing the risk of long-term
complications.
There has been no previous systematic review of this
area. The objective of this study is to systematically
review studies evaluating the fear of hypoglycaemia in
parents of children under 12 years of age with type 1 dia-
betes, assess the effect on hypoglycaemia avoidance
behaviour and on glycaemic control, and identify inter-
ventions which are effective in reducing fear of hypogly-
caemia and hypoglycaemia avoidance behaviour.
Methods
The review was carried out systematically, following the
general principles recommended by the Centre for
Reviews and Dissemination (CRD 2009) [16].
Inclusion criteria
Study design
Study designs of any type were eligible for inclusion.
Types of participants
Parents (or other primary carers) of children under 12
years with type 1 diabetes. Children on any insulin regi-
men were included.
Outcomes
• The extent of parental fear of hypoglycaemia
• The effect of parental hypoglycaemia avoidance 
behaviour on child's glycaemic control as reflected in 
HbA1c or frequency of hypoglycaemic episodes or 
admissions for metabolic derangements
• The effect of parental fear of hypoglycaemia on par-
ent's quality of life, anxiety, and depression,
• The impact of any intervention aimed at reducing 
parental fear of hypoglycaemia and hypoglycaemia 
avoidance behaviour.
Search strategy
The search strategy comprised the following main ele-
ments:
• Searching of electronic databases: The Cochrane 
Library (Issue 1, 2010); MEDLINE (1950-March 
2010); Embase (1980-March 2010); Science Citation 
Index Expanded (1970-March 2010); Social Sciences 
Citation Index (1970-March 2010); Conference Pro-Barnard et al. BMC Pediatrics 2010, 10:50
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ceedings Citation Index-Science (1990-present); 
PsycINFO (1967-March 2010).
• Meeting abstracts of European for the Study of Dia-
betes (EASD); American Diabetes Association 
(ADA); Diabetes UK.
• Current Controlled Trials; ClinicalTrials.gov; UK 
Clinical Research Network
• Contact with experts in the field
• Scrutiny of bibliographies of retrieved papers
No language or date restrictions were applied to the
search. Further details of the full search strategy are
reported in Appendix I
Study selection
Titles and abstracts were examined for inclusion by two
reviewers. Full copies of papers which appeared to fulfil
the inclusion criteria (or where there was doubt) were
obtained and were independently selected by two review-
ers for inclusion in either phase of the review. Disagree-
m e n t s  w e r e  r e s o l v e d  b y  d i s c u s s i o n  ( s e e  F i g u r e  1  f o r
inclusion/exclusions).
Quality Assessment
The quality of each study was assessed using tools appro-
priate to the study design: based on the 'Crombie criteria'
for assessment of cross-sectional studies [17] adapted by
Petticrew and colleagues[18]. Quality was assessed inde-
pendently by two reviewers. Disagreements were
resolved through discussion.
Data extraction
Data were extracted independently by one reviewer using
a standardised data extraction table and checked for
accuracy by a second reviewer. Disagreements were
resolved through discussion and with reference to the
original article.
Data analysis
A meta-analysis was not possible due to the lack of data
and the differences in populations and outcome mea-
sures. Studies were, therefore combined in a narrative
synthesis. Possible reasons for conflicting results were
also reported narratively.
Differences by treatment (multiple daily injections ver-
sus insulin pump therapy versus conventional regimens)
were to be explored in subgroup analysis but treatment
regimen was not reported in most of the studies.
Results
Of 1649 abstracts originally screened, 199 met the initial
inclusion criteria for retrieval of full papers for further
investigation. Following extensive screening, only eight
papers from six studies met the full inclusion criteria,
with no intervention studies applicable for inclusion. All
articles reported cross-sectional studies with one cross
sectional/correlational study. Quality Assurance data is
presented in Appendix II. Results of data extraction are
presented in tables Appendix III. The studies in this sec-
tion will be referred to by the surname of the first author
and year of the study.
Additional file 1 contains data extraction results in
Tables 1, 2 and 3.
Demographic Data
The number of parent/caregiver participants taking part
ranged from 24 to 114 (mean = 79). The number of child
participants was reported in four studies Patton 2008
[19], Clark 1998 [20], Mueller-Godeffroy 2009 [21] and
Marrero 1997 [22], and was 81, 46, 38 and 32 respectively,
with an earlier paper, (Patton 2007 [23]), reporting results
in a subset of 24 on CSII. Female parents/caregivers made
up 100% of participants in the Jaser 2009 study [24]; drop-
ping to 82-84% in Patton 2007 [23] and 60% in Patton
2008 [19]. One study, Mitchell 2009 [25], reporting a sub-
set of the participants in the Monaghan 2009 study [26]
included only male parent/caregivers as participants.
The ages of participating children ranged across studies
from 2 to 11 years (means 4.45 +/- 1.5 to 5.7 +/- 1.8
years). The duration of the children's diabetes was less
than 3.5 years in all studies, ranging from one month to
five years.
Insulin regimens
The insulin regimens reported included insulin pump
therapy, basal bolus/multiple daily injections and conven-
tional 2-3 injections a day. HbA1c was reported in five
studies, Patton 2008 [19], Clarke 1998 [20], Mueller-God-
effroy 2009 [21], Jaser 2009 [24], and Monaghan 2009
[26], and ranged from 6.0% to 11% (mean 8.19%).
Fear of hypoglycaemia
The commonest instrument used was the Hypoglycaemia
Fear Survey (HFS) with the parent version (HFS parent)
being used in all studies.
Mothers of young children with Type 1 diabetes in the
Patton 2008 study reported greater fear of hypoglycaemia
than fathers of young children (p = .006) and higher
scores on the behavioural subscale, (p = .001), but there
were no statistically significant differences between
mothers and fathers on the worry subscale[19]. Mitchell
2009 [25] reported low levels of hypoglycaemic fear in
fathers (mean = 16.7, range 0-44). Greater paternal paedi-
atric parenting stress however, in the Mitchell study, was
correlated with fathers' psychological resources including
lower self efficacy about diabetes management (r = -.46, p
=< .01), more fear of hypoglycaemia (r = .43, p =< .01),
more state anxiety (r = .67, p =< .001) and less hope (r = -
.60, p =< .001).
Half of participants in the Patton 2007 study reported
the child experiencing an episode of hypoglycaemia 3-5Barnard et al. BMC Pediatrics 2010, 10:50
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times per week [23]. However, the Patton 2008 study
reported that severity of hypoglycaemia was more impor-
tant in causing fear than frequency, especially in parents
whose child had experienced a hypoglycaemic seizure.
They also found that almost a third of children (32%) had
experienced at least one hypoglycaemia seizure during
their lifetime [19]. Marrero 1997 [22] reported that par-
ents of children who had experienced a hypoglycaemic
seizure within the past year had significantly greater
overall fear of hypoglycaemia (both behaviour and worry
scales) than those whose children had not experienced a
seizure. Furthermore, children who had experienced a
seizure with loss of consciousness had a significantly
higher percentage of self monitoring of blood glucose
Figure 1 Flow Diagram of Selection Process.
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(SMBG) values above the desired target range than young
children with no history of seizures (p = 0.03). Clark 1998
[20] supports this finding in that mothers whose children
had a history of passing out had significantly higher HFS
scores than mothers whose children had never lost con-
sciousness (79.6 +/- 13.9 versus 70.2 +/- 14.7, p = .040).
Patton 2007 [23] reported similar findings, although not
statistically significant, with parents of young children
who had seizures worrying more than parents of children
who had not (50.7 +/- 12.6 versus 41.7 +/- 9.6 respec-
tively). In the Marrero 1997 study there was no significant
correlation between the parental HFS total score and
parental DQoL general worry about their child having
diabetes (r = 0.34, p =< 0.06) [22].
Mothers' level of fear (as assessed by the HFS) did not
relate to the number of hypoglycaemic episodes over the
previous twelve months in Clarke 1998 [20]. However,
Monaghan 2009 reported that mothers' level of fear was
related to their degree of distress over hypoglycaemic epi-
sodes that occurred when their child was asleep (r = .372,
p = .005) or in social situations (r = .279, p = .03); but was
not related to maternal confidence in their ability to treat
hypoglycaemia or to their confidence at being able to rec-
ognise hypos [26].
Patton 2007 reported that the most common fears
reported by parents relating to hypoglycaemia were feel-
ing the child will have a low blood glucose while asleep
(63% of participants), and the child having a low blood
glucose when away from a parent (46%) [23]. Additional
results from this study suggest that parents of children
with higher average blood glucose levels reported greater
fear of hypoglycaemia (p = 0.05), with a trend between
parents' worry score and children's daily blood glucose
control (p = 0.06).
Anxiety and depression
Increased maternal depression and anxiety were associ-
ated with greater fear of hypoglycaemia in Jaser 2009 [24].
This study also reported, however, that maternal symp-
toms of anxiety and depression were not related to child's
metabolic control. Although surprisingly, in most chil-
dren HbA1c was below the treatment goals recom-
mended for their age group (average HbA1c 6.86% SD
0.86).
Patton 2008 reported that parental anxiety includes
"not being there" if the child needs them whilst they are
asleep alongside concerns that their child will 'have a
hypo' during the night [19].
Socio-economic influences
Patton 2007 found that negative associations were
reported between families' socioeconomic status and
total/worry scales on the HFS (p < 0.001 and p =< 0.05
respectively). Also, family income and education was
related to mother's coping resources (i.e. resources cur-
rently available to individuals for managing stress) [23].
Further evidence of socioeconomic influence were found
by Jaser 2009, who reported that lower income levels and
finding it more upsetting to cope with diabetes related
stress, accounted for higher symptoms of anxiety and
stress in mothers. Monaghan 2009 reported that Cauca-
sian parents and those with higher education reported
greater fear associated with hypoglycaemia. Fewer years
of education and lower income were reported to produce
a greater state anxiety in Patton 2007 and Monaghan 20
[23,26].
S t a l l w o o d  r e p o r t e d  t h a t  p a r e n t s  w i t h  c h i l d r e n  w h o
maintained HbA1c within a target range had higher
incomes and knowledge levels than those with children
with HbA1c levels outside target range (p =/< 0.05 and p
=/< 0.01 respectively) [27].
Hypoglycaemic avoidance behaviour
Patton 2007 reported that parents of children with higher
than average blood glucose levels were reported to
engage in frequent use of behaviours aimed at preventing
hypoglycaemia as assessed by the HFS PYC behaviour
score (p = 0.04).
The higher scores in mothers on the behavioural sub-
scale of the HFS indicated greater use of maladaptive
coping behaviours to avoid hypoglycaemia (such as 'have
my child eat large snacks at bedtime' and 'allow my child's
blood glucose to be a little high to be on the safe side'
items on HFS) in Patton 2008 [19].
Common strategies used by parents to prevent hypo-
glycaemia in Patton 2007 were carrying fast-acting sugar
(100%), checking blood glucose often when attending a
long event (75%), avoiding being away from their child
when his/her blood glucose might go low (67%), feeding
the child at the first sign of hypoglycaemia (63%) [23].
Monaghan 2009 reported that parents often engage in
nocturnal blood glucose monitoring, and those who
reported 'often/always' were more likely to have a child on
a basal-bolus regimen and their child having significantly
longer illness duration (p =< 0.05) [26].
Discussion
We found that the evidence base on fear of hypoglycae-
mia amongst parents, and its effect on their quality of life,
is quite limited. However, fear of hypoglycaemia was
common, especially amongst mothers. Hypoglycaemic
episodes are quite frequent, but the fear of hypos is
related more to the severity of hypoglycaemia than the
frequency, especially if the child has had a hypoglycaemic
convulsion. Parental anxiety and depression are common.
However, hypoglycaemic avoidance behaviour was rarely
reported, perhaps because it is a very sensitive topic. We
heard anecdotal evidence from personal communicationBarnard et al. BMC Pediatrics 2010, 10:50
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with healthcare professionals at Southampton and Leeds
Paediatric Diabetes Centres that some parents have a ten-
dency to run blood glucose levels 'slightly' higher than
recommended to avoid acute episodes of hypoglycaemia,
resulting in higher HbA1c. Parents, especially mothers,
the main carers, may seek to avoid hypoglycaemia as indi-
cated on the behaviour subscale of the HFS-P [19,28].
Parental fears include fear of hypoglycaemia and asso-
ciated seizures; anxiety associated with frequent blood
glucose monitoring; fear of 'not being there'; general anxi-
ety associated with the burden of caring for a child with
Type 1 diabetes and fear that others, such as babysitters,
teachers and others will be unable to provide appropriate
care for their child [29]. Nocturnal hypoglycaemia in par-
ticular poses particular stressors to mothers, irrespective
of the number of hypoglycaemic episodes reported. Mon-
aghan [26] reports that frequency of nocturnal blood glu-
cose monitoring was positively associated with parent
reported anxiety and parenting stress (p =< 0.05).
One problem if blood glucose is allowed to run chroni-
cally high is that the signs and symptoms of acute hypo-
glycaemia may present at higher blood glucose levels i.e.
above 4 mmol rather than 3.9 and below, when the
patient is actually not hypoglycaemic. This can happen
when blood glucose has dropped from a higher reading
or when blood glucose readings are very variable.
The risk of severe hypoglycaemia can be minimised by
appropriate self-monitoring of blood glucose, regular
review of insulin regimen, review of the quantity and tim-
ing of carbohydrate intake, and the use of CSII [12].
A Norwegian study was excluded from this review
because it covered an age range up to 15, with about 40%
of children outside our age range of interest, and did not
give results split by age band [28]. Parents of 115 children
participated, completing the Hypo Fear Survey Parent
version. Mothers scored significantly higher than fathers
on both worry and behaviour subscales (p =< 0.001) sug-
gesting that mothers may engage in hypoglycaemia avoid-
ance behaviours. Parents of children receiving insulin
injections scored higher than parents of children using
CSII on the behaviour subscale (P =< 0.001) but for all
parents, severe hypoglycaemia in a child is one of the
most important causes of fear. The level of fear was not
correlated with the number of hypoglycaemic episodes,
but was related to their severity, especially in mothers of
children who have experienced a hypoglycaemic seizure.
The authors conclude that future interventions should
target both parental fear and appropriate ways to prevent
hypoglycaemia in children with Type 1 diabetes [28].
Overall, the methodological quality of the cross sec-
tional studies (as shown in Table 1 in Appendix III) was
good. All studies were recruited appropriately, from pae-
diatric diabetes clinics. In four studies it seemed that par-
ticipants in the study were a representative sample of the
clinic population, whereas in the other two studies it was
unclear. One study (Mueller-Godeffroy 2009 [21]) met all
seven quality indicators, three studies met six criteria,
and two met four criteria. The most common method-
ological limitation was the lack of a power calculation to
justify whether the sample size used in the study was ade-
quate. Only two studies reported doing such a calcula-
tion. The other limitation in some studies was the
response rate. We defined a good response rate as 70% or
more, in line with good practice recommendations [30].
Two studies did not report the response rate, and of the
remainder, three were good and one, Jaser 2009 [24] was
low (40%). This could be a possible source of bias if non-
responders differ in some way with respect to the variable
being measured.
The main limitation of the current review was the very
limited evidence base. Furthermore, the complex and
multifaceted issues affecting parental fear of hypoglycae-
mia still require further exploration. There were few
papers that specifically addressed the issue of fear of
hypoglycaemia separately from wider parental anxiety
associated with the diagnosis and treatment of a child
with Type 1 diabetes. This is a highly sensitive area and it
could be that well designed, robust qualitative research is
required to tease out parental attitudes is a more sensitive
way than could be achieved using quantitative methods.
We need to know if there are interventions which could
alleviate the burden of fear associated with hypoglycae-
mia. Could a structured education course for parents
help? In the UK, parents of children aged up to 12 years
with Type 1 diabetes currently do not receive any struc-
tured education on how best to manage their child's bio-
medical and psychosocial needs. There is no evidence of
whether a structured education programme for parents
of young children would be helpful. Better understanding
of the disease might overcome any tendency of parents to
allow poor glycaemic control because of fear of hypogly-
caemia.
Structured education programmes have been used for
older patients. DAFNE (Dose Adjustment for Normal
Eating) is a 5-day out-patient course for adults with Type
1 diabetes, teaching the skills of carbohydrate counting
and insulin dose adjustment. An RCT of DAFNE
reported improvements in glycaemic control, satisfaction
with treatment, and quality of life compared to those
receiving standard care [31].
A structured education programme, KICk-OFF(Kids in
Control of Food (KICk OFF), for 11 to 16 year olds with
Type 1 diabetes based on the DAFNE principles, is cur-
rently the subject of an RCT. The pilot study of the course
found significant improvements in quality of life, satisfac-
tion with diabetes treatment and self-efficacy on child
and parent reports, 6-months after completing theBarnard et al. BMC Pediatrics 2010, 10:50
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course. Glycaemic control in those with poor control at
baseline also improved at 6-months post-course [32].
Parents from lower socioeconomic backgrounds report
finding it harder to cope [23,24], thus interventions may
needed to be tailored to take account of these differences.
Conclusion
Parents of a child with Type 1 diabetes report a high level
of anxiety and fear associated with managing the condi-
tion. Further research is needed to determine whether
fear of hypoglycaemia leads to poorer glycaemic control
because of hypoglycaemia avoidance behaviour, and
whether structured education courses for parents would
be effective in reducing worry and improving control.
Appendix I
The MEDLINE search strategy (below) was adapted as
appropriate for other databases
1. exp Diabetes Mellitus, Type 1/
2. type 1 diabet*.tw.
3. (child* adj2 diabet*).tw.
4. 1 or 3 or 2
5. exp Parents/
6. (maternal or mother* or paternal or father* or 
famil* or parent or parents or carer*).tw.
7. 6 or 5
8. exp Hypoglycemia/
9. hypoglyc*.tw.
10. 8 or 9
11. 4 and 7 and 10
Appendix II
Quality Assessment
Cross sectional studies
1. Was the research design appropriate?
2. Was the recruitment strategy appropriate?
3. What was the response rate?
4. Is the sample representative?
5. Were objective and reliable measurements used?
6. Was there a power calculation or justification of 
numbers?
7. Was the statistical analysis appropriate?
8. Was there evidence of bias in the study?
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